MEX3A promotes cell proliferation by regulating the RORA/β-catenin pathway in hepatocellular carcinoma

doi:10.4251/wjgo.v17.i4.102084

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 4

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (219)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-9) series, Tables (1-1) series.

Item

Count

PDF

HTML

Figures (1-9)

Tables (1-1)

Sum=112

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=78

Publishing Process of This Article

Item

Count

Browse

Download

Sum=5

Apr 15, 2025 (publication date) through Mar 31, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Gastrointest Oncol. Apr 15, 2025; 17(4): 102084
Published online Apr 15, 2025. doi: 10.4251/wjgo.v17.i4.102084

Full Size Figure Download Figure

Figure 1 Analysis of MEX3A expression. A: Differential expression of MEX3A mRNA in hepatocellular carcinoma (HCC) and adjacent non-tumor tissues (P < 0.001); B and C: Differential expression of MEX3A mRNA in HCC according to age (P = 0.013) and tumor-node-metastasis stages (P < 0.001); D: Kaplan-Meier survival analysis of MEX3A in HCC (P < 0.0001).

Citation: Ji PX, Zhang P, Zhou HL, Yu H, Fu Y. MEX3A promotes cell proliferation by regulating the RORA/β-catenin pathway in hepatocellular carcinoma. World J Gastrointest Oncol 2025; 17(4): 102084
URL: https://www.wjgnet.com/1948-5204/full/v17/i4/102084.htm
DOI: https://dx.doi.org/10.4251/wjgo.v17.i4.102084